Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Watch CNBC's full interview with Teva CEO Richard Francis - YouTube
Teva says Israel-Hamas war not hurting production, eyes growth in 2024 | Reuters
6 reasons to buy Teva Pharmaceuticals stock sooner than later — TradingView News
Teva Pharmaceuticals found to be responsible for its role in the opioid epidemic in New York state | CNN
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals - Next generation supply chain transformation by digitalisation at Teva by iThink Media - Issuu
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum | AlphaStreet
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva to pay $225M to settle cholesterol drug price-fixing charges | AP News
The Citizen Newspaper Group
Teva Pharmaceutical Industries Ltd (ADR) Announces the Launch of Generic Equivalents to Syprine
Teva Pharma CEO Richard Francis on Q4 earnings
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva seeks CEO replacement as Shultz will retire in 2023: WSJ
Teva Elevates Its Signature Sandals With Pops of Color for Pride 2023 – Footwear News
TEVA Stock Pops 4% as Teva Receives FDA Approval | InvestorPlace
Alan George - Associate Director, Executive Recruitment - Teva Pharmaceuticals | LinkedIn
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video